Diabetes Prevalence in Sweden at Present and Projections for Year 2050

被引:56
作者
Andersson, Tomas [1 ,2 ]
Ahlbom, Anders [1 ,2 ]
Carlsson, Sofia [1 ]
机构
[1] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden
[2] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden
关键词
MORTALITY; MELLITUS; TRENDS; REGISTER; BURDEN; COHORT; RATES;
D O I
10.1371/journal.pone.0143084
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background Data on the future diabetes burden in Scandinavia is limited. Our aim was to project the future burden of diabetes in Sweden by modelling data on incidence, prevalence, mortality, and demographic factors. Method To project the future burden of diabetes we used information on the prevalence of diabetes from the national drug prescription registry (adults >= 20 years), previously published data on relative mortality in people with diabetes, and population demographics and projections from Statistics Sweden. Alternative scenarios were created based on different assumptions regarding the future incidence of diabetes. Results Between 2007 and 2013 the prevalence of diabetes rose from 5.8 to 6.8% in Sweden but incidence remained constant at 4.4 per 1000 (2013). With constant incidence and continued improvement in relative survival, prevalence will increase to 10.4% by year 2050 and the number of afflicted individuals will increase to 940 000. Of this rise, 30% is accounted for by changes in the age structure of the population and 14% by improved relative survival in people with diabetes. A hypothesized 1% annual rise in incidence will result in a prevalence of 12.6% and 1 136 000 cases. Even with decreasing incidence at 1% per year, prevalence of diabetes will continue to increase. Conclusion We can expect diabetes prevalence to rise substantially in Sweden over the next 35 years as a result of demographic changes and improved survival among people with diabetes. A dramatic reduction in incidence is required to prevent this development.
引用
收藏
页数:10
相关论文
共 22 条
[1]
The magnitude of association between overweight and obesity and the risk of diabetes: A meta-analysis of prospective cohort studies [J].
Abdullah, Asnawi ;
Peeters, Anna ;
de Courten, Maximilian ;
Stoelwinder, Johannes .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (03) :309-319
[2]
Prevalence and Incidence of Diabetes in Stockholm County 1990-2010 [J].
Andersson, Tomas ;
Ahlbom, Anders ;
Magnusson, Cecilia ;
Carlsson, Sofia .
PLOS ONE, 2014, 9 (08)
[3]
[Anonymous], 2005, GUID ATC CLASS DDD A
[4]
Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence [J].
Boyle, James P. ;
Thompson, Theodore J. ;
Gregg, Edward W. ;
Barker, Lawrence E. ;
Williamson, David F. .
POPULATION HEALTH METRICS, 2010, 8
[5]
Prevalence of type 2 diabetes in Germany in 2040: estimates from an epidemiological model [J].
Brinks, Ralph ;
Tamayo, Teresa ;
Kowall, Bernd ;
Rathmann, Wolfgang .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2012, 27 (10) :791-797
[6]
The Danish National Diabetes Register: trends in incidence, prevalence and mortality [J].
Carstensen, B. ;
Kristensen, J. K. ;
Ottosen, P. ;
Borch-Johnsen, K. .
DIABETOLOGIA, 2008, 51 (12) :2187-2196
[7]
Improved survival in both men and women with diabetes between 1980 and 2004-a cohort study in Sweden [J].
Eliasson, Mats ;
Talback, Mats ;
Rosen, Mans .
CARDIOVASCULAR DIABETOLOGY, 2008, 7 (1)
[8]
Trends in Death Rates Among US Adults With and Without Diabetes Between 1997 and 2006 Findings from the National Health Interview Survey [J].
Gregg, Edward W. ;
Cheng, Yiling J. ;
Saydah, Sharon ;
Cowie, Catherine ;
Garfield, Sanford ;
Geiss, Linda ;
Barker, Lawrence .
DIABETES CARE, 2012, 35 (06) :1252-1257
[9]
Global estimates of diabetes prevalence for 2013 and projections for 2035 [J].
Guariguata, L. ;
Whiting, D. R. ;
Hambleton, I. ;
Beagley, J. ;
Linnenkamp, U. ;
Shaw, J. E. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (02) :137-149
[10]
Gudbjornsdottir S., 2013, NAT DIAB REG SWED